195
Views
77
CrossRef citations to date
0
Altmetric
Original

MMP-2 Levels are Elevated in the Plasma of Women Who Subsequently Develop Preeclampsia

, B.M.B.S., , , , M.D., , M.D. & , Ph.D.
Pages 103-115 | Published online: 07 Jul 2009

References

  • Ashworth J R, Warren A Y, Baker P N, Johnson I R. Loss of endothelium-dependent relaxation in myometrial resistance arteries in pre-eclampsia. Br J Obstet Gynaecol 1997; 104(10):1152–1158. [PUBMED], [INFOTRIEVE], [CSA]
  • Hayman R, Warren A, Brockelsby J, Johnson I, Baker P. Plasma from women with pre-eclampsia induces an in vitro alteration in the endothelium-dependent behaviour of myometrial resistance arteries. Br J Obstet Gynaecol 2000; 107(1):108–115.
  • Myers J E, Mires G J, Macleod M, Baker P N. In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease. J Soc Gynecol Investig 2003; 10(2 supp):172. [CSA]
  • Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski M W. Release of gelatinase A during platelet activation mediates aggregation. Nature 1997; 386(6625):616–619. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Fernandez-Patron C, Radomski M W, Davidge S T. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 1999; 85(10):906–911. [PUBMED], [INFOTRIEVE]
  • Fernandez-Patron C, Stewart K G, Zhang Y, Koivunen E, Radomski M W, Davidge S T. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 2000; 87(8):670–676. [PUBMED], [INFOTRIEVE]
  • Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477(1–2):267–283. [PUBMED], [INFOTRIEVE]
  • Merchant S J, Narumiya H, Zhang Y, Guilbert L J, Davidge S T. The effects of preeclampsia and oxygen environment on endothelial release of matrix metalloproteinase-2. Hypertens Pregnancy 2004; 23(1):47–60. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Kolben M, Lopens A, Blaser J, Ulm K, Schmitt M, Schneider K T, Tschesche H. Proteases and their inhibitors are indicative in gestational disease. Eur J Obstet Gynecol Reprod Biol 1996; 68(1–2):59–65. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Mires G J, Williams F L, Leslie J, Howie P W. Assessment of uterine arterial notching as a screening test for adverse pregnancy outcome. Am J Obstet Gynecol 1998; 179(5):1317–1323. [PUBMED], [INFOTRIEVE], [CSA]
  • Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183(1):S1–S22. [CSA], [CROSSREF]
  • Wilcox M A, Johnson I R, Maynard P V, Smith S J, Chilvers C E. The individualised birthweight ratio: a more logical outcome measure of pregnancy than birthweight alone. BJOG 1993; 100(4):342–347.
  • Heussen C, Dowdle E B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980; 102(1):196–202. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Merchant S J, Crocker I P, Baker P N, Tansinda D, Davidge S T, Guilbert L J. Matrix metalloproteinase release from placental explants of pregnancies complicated by intrauterine growth restriction. J Soc Gynecol Investig 2004; 11(2):97–103. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Narumiya H, Zhang Y, Fernandez-Patron C, Guilbert L J, Davidge S T. Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy 2001; 20(2):185–194., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Hunter A, Aitkenhead M, Caldwell C, McCracken G, Wilson D, McClure N. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 2000; 36(6):965–969. [PUBMED], [INFOTRIEVE]
  • Chappell L C, Seed P T, Briley A, Kelly F J, Hunt B J, Charnock-Jones D S, Mallet A I, Poston L. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187(1):127–136. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Chavarria M E, Lara-Gonzalez L, Gonzalez-Gleason A, Sojo I, Reyes A. Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: a longitudinal study for early prediction of preeclampsia. Am J Obstet Gynecol 2002; 187(3):595–601. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Yakubenko V P, Lobb R R, Plow E F, Ugarova T P. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4) beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Exp Cell Res 2000; 260(1):73–84. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Park H Y, Kwon H M, Lim H J, Hong B K, Lee J Y, Park B E, Jang Y, Cho S Y, Kim H S. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001; 33(2):95–102. [PUBMED], [INFOTRIEVE]
  • Yan L, Moses M A, Huang S, Ingber D E. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. J Cell Sci 2000; 113(pt 22):3979–3987. [PUBMED], [INFOTRIEVE]
  • Bassiouny H S, Song R H, Hong X F, Singh A, Kocharyan H, Glagov S. Flow regulation of 72-kD collagenase IV (MMP-2) after experimental arterial injury. Circulation 1998; 98(2):157–163. [PUBMED], [INFOTRIEVE], [CSA]
  • Chesler N C, Ku D N, Galis Z S. Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. Am J Physiol 1999; 277(5 pt 2):H2002–H2009. [PUBMED], [INFOTRIEVE]
  • Roggensack A M, Zhang Y, Davidge S T. Evidence for peroxynitrite formation in the vasculature of women with preeclampsia. Hypertension 1999; 33(1):83–89. [PUBMED], [INFOTRIEVE], [CSA]
  • Rajagopalan S, Meng X P, Ramasamy S, Harrison D G, Galis Z S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98(11):2572–2579. [PUBMED], [INFOTRIEVE], [CSA]
  • Frears E R, Zhang Z, Blake D R, O'Connell J P, Winyard P G. Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett 1996; 381(1–2):21–24. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Fernandez-Patron C, Zouki C, Whittal R, Chan J S, Davidge S T, Filep J G. Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1–32. Faseb J 2001; 15(12):2230–2240. [PUBMED], [INFOTRIEVE], [CROSSREF]
  • Myers J E, Macleod M, Mires G J, Baker P. In pre-eclampsia (PE), circulating factor(s) precede clinical disease, irrespective of mid-trimester doppler waveform and development of associatiated IUGR. J Soc Gynecol Investig 2004; 11(2 supp):267.
  • Merchant S J, Davidge S T. The role of matrix metalloproteinases in vascular function: implications for normal pregnancy and preeclampsia. BJOG 2004; 111(9):931–939. [PUBMED], [INFOTRIEVE], [CSA]
  • Romero R, Chaiworapongsa T, Espinoza J, Gomez R, Yoon B H, Edwin S, Mazor M, Maymon E, Berry S. Fetal plasma MMP–9 concentrations are elevated in preterm premature rupture of the membranes. Am J Obstet Gynecol 2002; 187(5):1125–1130. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
  • Stygar D, Wang H, Vladic Y S, Ekman G, Eriksson H, Sahlin L. Increased level of matrix metalloproteinases 2 and 9 in the ripening process of the human cervix. Biol Reprod 2002; 67(3):889–894. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.